Безопасен ли hexapeptide-39 при беременности?

Related ingredients

Frequently asked questions

Безопасен ли hexapeptide-39 при беременности?

No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment located, and no peer‑reviewed reproductive or developmental toxicity studies identified for hexapeptide‑39. As a short peptide (no small‑molecule structural alerts) it has no documented reproductive hazard; topical dermal absorption is expected to be negligible for peptides, so systemic exposure in pregnancy is unlikely.

Безопасен ли hexapeptide-39 при грудном вскармливании?

No evidence of reproductive or lactation toxicity and no harmonised classification. Peptides of this type lack data indicating breastmilk transfer after topical use; expected systemic exposure from topical application is negligible.

Безопасен ли hexapeptide-39 для кожи малыша?

No infant‑specific safety or toxicity data found. Peptides are generally large and hydrophilic with very low percutaneous absorption; therefore exposure to a breastfed infant or to baby skin from topical application is expected to be negligible. No evidence found to justify increasing hazard or mechanism scores for infants.

Как VeriMom оценивает hexapeptide-39?

VeriMom оценивает hexapeptide-39 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы hexapeptide-39 при беременности?

См. наш список безопасных альтернатив hexapeptide-39 с аналогичной функцией и классификацией без известных рисков.